Please login to the form below

Not currently logged in
Email:
Password:

Precision BioSciences

This page shows the latest Precision BioSciences news and features for those working in and with pharma, biotech and healthcare.

Chinese biotech claims 90% cure rate for CAR-T therapy

Chinese biotech claims 90% cure rate for CAR-T therapy

In February, for example, Baxalta announced a $1.7bn alliance with Precision Biosciences, which is developing an off-the-shelf CAR-T technology that does not require cells to be taken

Latest news

  • Baxalta makes $1.7bn play for slice of CAR-T market Baxalta makes $1.7bn play for slice of CAR-T market

    Baxalta makes $1.7bn play for slice of CAR-T market. Three-year alliance with Precision BioSciences to expand immuno-oncology portfolio. ... Baxalta has made a play for a stake of the emerging CAR-T immunotherapy market with a $1.7bn, three-year alliance

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Deal Watch February 2016 Deal Watch February 2016

    Baxalta entered the chimeric antigen receptor (CAR) T-cell therapy area through its multi-programme immuno-oncology alliance with genome editing company, Precision BioSciences. ... acquisition - company. 2, 775. Precision Biosciences/ Baxalta. allogeneic

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics